|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1997-6-17
|
|
pubmed:abstractText |
We developed a charcoal suspension formulation to be injected intratumorally so that human breast cancers can be tatooed prior to chemotherapy. This deposit is intended to guide the surgeon at the time of the biopsy and resection, especially when the tumor nodule is not visible. The stain should remain in the tumor as long as the patient is on chemotherapy and should be harmless.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0724-8741
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
218-23
|
|
pubmed:dateRevised |
2003-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:9090713-Animals,
pubmed-meshheading:9090713-Charcoal,
pubmed-meshheading:9090713-Diffusion,
pubmed-meshheading:9090713-Dose-Response Relationship, Drug,
pubmed-meshheading:9090713-Female,
pubmed-meshheading:9090713-Injections, Intralesional,
pubmed-meshheading:9090713-Mammary Neoplasms, Experimental,
pubmed-meshheading:9090713-Mice,
pubmed-meshheading:9090713-Mice, Inbred C3H,
pubmed-meshheading:9090713-Neoplasm Transplantation,
pubmed-meshheading:9090713-Particle Size,
pubmed-meshheading:9090713-Suspensions
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Formulation of a charcoal suspension for intratumor injection. Part 1: Study of the nature, granulometry, and concentration.
|
|
pubmed:affiliation |
Département de Pharmacie, Hôpital Paul-Brousse, Villejuif, France.
|
|
pubmed:publicationType |
Journal Article
|
